Breast imaging device developer Imaging Diagnostic Systems has received an order for its CT Laser Mammography system (CTLM), a work-in-progress device that uses infrared laser light to image breast tissue. The company signed an agreement at the RSNA show
Breast imaging device developer Imaging Diagnostic Systems has received an order for its CT Laser Mammography system (CTLM), a work-in-progress device that uses infrared laser light to image breast tissue. The company signed an agreement at the RSNA show last month with Cycle of Life Technologies of Toronto for two of the units. The deal should bring in approximately $500,000, the first revenues generated by the Fort Lauderdale, FL, firm since it was established. IDSI expects to deliver the devices during the first quarter of next year.
The agreement also covers the delivery of two more CTLM devices once the first order has been fulfilled, as well as a distribution contract for 50 systems over the next two years. Cycle of Life Technologies supplies medical services and equipment to clients in Canada, Europe, South Africa, and the Middle East.
Since IDSI has yet to apply for premarket approval from the Food and Drug Administration for CTLM, the company must obtain an export certificate from the agency before it can ship the system. The certificate application must include letters from each country Cycle of Life Technologies services stating that the country will accept a non-FDA-approved device for import.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.